In this era of health data explosion thanks to the advancements in genome sequencing technologies, more electronic health records in different health systems, more patient registries, social media networks, medical and nonmedical device data systems (e.g., smartphones, fitness monitors, etc.), and advanced analytic tools, personalized medicine has never looked more promising.
Our panelists are part of a great group of companies that generate and analyze data to advance personalized medicine: BioVU Partnerships collaborates with researchers to study genotype-phenotype associations using BioVU’s over 180,000 samples of DNA repository obtained from patients; GRAIL focuses on the early detection of cancer using ctDNA and creates vast datasets through one of the largest clinical trial programs ever pursued in genomic medicine; Singlera Genomics develops non-invasive genetics testing methods and Med Data Quest applies machine learning to extract insights from EHR; and McKinsey is one of the leading consulting firms guiding investors and biotech companies in the field of personalized medicine.
Key questions to be addressed include:
Nicholas Donoghoe, MD, Partner, McKinsey & Company
Leeland Ekstrom, PhD, Managing Director, BioVU Partnerships, Vanderbilt University Medical Center & Founder, Nashville Biosciences
Gary (Yuan) Gao, PhD, Co-Founder, President and Chief Executive Officer, Med Data Quest, Inc. & Co-Founder and Chairman of the Board, Singlera Genomics
Tara Maddala, PhD, Head of Biostatistics and Data Management, GRAIL, Inc.
MODERATOR: Beni Surpin, Partner, Foley & Lardner LLP